Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD81 | P60033 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | BACE1 | P56817 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL337281 | 1.00 | CD81 (0.38) | CD81PTGS1PPARGBACE1CYP2C9 | |
| Hydrochloric Acid SCHEMBL9844191 | 0.98 | CD81 (0.37) | CD81PTGS1PPARGBACE1CYP2C9 | |
| SCHEMBL637285 | 0.87 | CD81 (0.36) | CD81PTGS1PPARGBACE1KDM4E | |
| SCHEMBL637283 | 0.87 | CD81 (0.36) | CD81PTGS1PPARGBACE1KDM4E | |
| Sulfuric Acid Dimethyl Ester SCHEMBL28693235 | 0.86 | CD81 (0.31) | CD81 | |
| SCHEMBL17423959 | 0.85 | EP300 (0.38) | CD81KDM4EALDH1A1TBXAS1 | |
| SCHEMBL4337785 | 0.84 | EP300 (0.41) | CD81KDM4ETBXAS1 | |
| SCHEMBL4334367 | 0.84 | EP300 (0.41) | CD81KDM4ETBXAS1 | |
| SCHEMBL28069094 | 0.82 | CD81 (0.41) | CD81PTGS1PPARGBACE1CYP2C9 | |
| SCHEMBL1274641 | 0.80 | POLB (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3681962-B1 | ACRYLIC EMULSIONS MODIFIED WITH FUNCTIONAL (METH)ACRYLATES TO ENABLE CROSSLINKING | Miwon North America Incorporated (US) | 2025-05-21 | — | — | EP | claimed |
| US-8063162-B2 | Polymer for an ink receiving layer of an inkjet recording element | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2011-11-22 | — | — | US | claimed |
| US-20110160416-A1 | POLYMER FOR AN INK RECEIVING LAYER OF AN INKJET RECORDING ELEMENT | CHEN TIENTEH | 2011-06-30 | — | — | US | claimed |
| US-7923117-B2 | first monomer of the polymer includes at least one amine functional group; aminoethylmethacrylate; aminoethylacrylate; second monomer includes a carbon backbone having at least one silane functional group pendant; prevent dye from migrating | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) | 2011-04-12 | — | — | US | claimed |
| EP-0075957-B1 | CURABLE MOLDING COMPOSITIONS CONTAINING A POLY(ACRYLATE) | UNION CARBIDE CORPORATION (US) | 1986-01-22 | — | — | EP | claimed |
| US-12460050-B2 | Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 2025-11-04 | — | — | US | disclosed |
| EP-3673006-B1 | COMPOSITION COMPRISING CARBON FIBERS AND AN ADDITIVE AGENT | BYK CHEMIE GMBH (DE) | 2021-08-18 | — | — | EP | disclosed |
| US-20200332061-A1 | NITRIC OXIDE-RELEASING HYPERBRANCHED COMPOUNDS AS ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2020-10-22 | — | — | US | disclosed |
| EP-3673006-A1 | COMPOSITION COMPRISING CARBON FIBERS AND AN ADDITIVE AGENT | BYK-Chemie GmbH (DE) | 2020-07-01 | — | — | EP | disclosed |
| US-20200199316-A1 | COMPOSITION COMPRISING CARBON FIBERS AND AN ADDITIVE AGENT | BYK-CHEMIE GMBH (DE) | 2020-06-25 | — | — | US | disclosed |
| US-10501590-B2 | Solid composites containing polymeric matrix with carbon fibers embedded therein | UT-BATTELLE, LLC (US) | 2019-12-10 | — | — | US | disclosed |
| US-10457785-B2 | Method of improving adhesion of carbon fibers with a polymeric matrix | UT-BATTELLE, LLC (US) | 2019-10-29 | — | — | US | disclosed |
| WO-2006082234-A1 | METHOD FOR THE PRODUCTION OF AN AQUEOUS POLYMER DISPERSION | BASF AKTIENGESELLSCHAFT (DE) | 2006-08-10 | — | — | WO | disclosed |
| WO-2006072464-A1 | METHOD FOR PRODUCING AQUEOUS COMPOSITE PARTICLE DISPERSIONS | BASF AKTIENGESELLSCHAFT (DE) | 2006-07-13 | — | — | WO | disclosed |
| WO-2006048167-A1 | COATING MATERIALS | BASF AKTIENGESELLSCHAFT (DE) | 2006-05-11 | — | — | WO | disclosed |
| EP-1618254-A2 | METHOD FOR THE TREATMENT OF PAPER SURFACES | BASF AKTIENGESELLSCHAFT (DE) | 2006-01-25 | — | — | EP | disclosed |
| WO-2005083015-A1 | METHOD FOR IMPROVING THE STORAGE STABILITY OF COMPOSITE PARTICLE DISPERSIONS | BASF AKTIENGESELLSCHAFT (DE) | 2005-09-09 | — | — | WO | disclosed |
| EP-1235869-B1 | METHOD FOR PRODUCING AN AQUEOUS DISPERSION OF PARTICLES THAT ARE MADE UP OF POLYMERS AND INORGANIC SOLID MATTER WHICH CONSISTS OF FINE PARTICLES | BASF AG (DE) | 2004-12-01 | — | — | EP | disclosed |
| WO-2004092481-A2 | METHOD FOR THE TREATMENT OF PAPER SURFACES | BASF AKTIENGESELLSCHAFT (DE) | 2004-10-28 | — | — | WO | disclosed |
| EP-1431356-A2 | Use of aqueous dipersion of particles made up of polymerisate and fine inorganic solid material for priming mineral substrates | Basf AG (DE) | 2004-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12460050-B2 | Nitric oxide-releasing hyperbranched compounds as antibacterial scaffolds and methods pertaining thereto | NOS2, NOS1, NOS3 | CD81 3935/4885PTGS1 66/4885PPARG 3224/4885 |
| US-20200332061-A1 | NITRIC OXIDE-RELEASING HYPERBRANCHED COMPOUNDS AS ANTIBACTERIAL SCAFFOLDS AND METHODS PERTAINING THERETO | NOS2, NOS1, NOS3 | CD81 3935/4885PTGS1 66/4885PPARG 3224/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.